On this episode, Alex explores the role of synthetic data in health care and life sciences with Harry Keen, Co-Founder of Hazy, and Dr. Mark Lambrecht, Global Head of Health and Life Sciences Advisory at SAS. The conversation explores practical use cases for synthetic data in the health ecosystem as well as important limitations and considerations for ensuring security and governance.

A core challenge for all health and life sciences organizations is the fragmented and decentralized nature of their data. Keen and Dr. Lambrecht agree that synthetic data can be used to remove barriers, improve efficiency and test approaches to extract more value from existing data, thereby driving innovation and enhancing patient outcomes. Tune in to hear their advice for all leaders interested in building or growing the utility of synthetic data for their organizations.